| Product Code: ETC9106831 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Samoa Oncology Companion Diagnostic Market Overview |
3.1 Samoa Country Macro Economic Indicators |
3.2 Samoa Oncology Companion Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Samoa Oncology Companion Diagnostic Market - Industry Life Cycle |
3.4 Samoa Oncology Companion Diagnostic Market - Porter's Five Forces |
3.5 Samoa Oncology Companion Diagnostic Market Revenues & Volume Share, By Product & Service, 2021 & 2031F |
3.6 Samoa Oncology Companion Diagnostic Market Revenues & Volume Share, By Technology(Revenue, USD Million, 2021-2031), 2021 & 2031F |
3.7 Samoa Oncology Companion Diagnostic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 Samoa Oncology Companion Diagnostic Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Samoa Oncology Companion Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Samoa |
4.2.2 Growing adoption of personalized medicine in oncology |
4.2.3 Advancements in diagnostic technologies for oncology companion diagnostics |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure and resources in Samoa |
4.3.2 High cost associated with companion diagnostic tests |
4.3.3 Regulatory challenges in the approval and adoption of new companion diagnostic tests |
5 Samoa Oncology Companion Diagnostic Market Trends |
6 Samoa Oncology Companion Diagnostic Market, By Types |
6.1 Samoa Oncology Companion Diagnostic Market, By Product & Service |
6.1.1 Overview and Analysis |
6.1.2 Samoa Oncology Companion Diagnostic Market Revenues & Volume, By Product & Service, 2021- 2031F |
6.1.3 Samoa Oncology Companion Diagnostic Market Revenues & Volume, By Product, 2021- 2031F |
6.1.4 Samoa Oncology Companion Diagnostic Market Revenues & Volume, By Service, 2021- 2031F |
6.2 Samoa Oncology Companion Diagnostic Market, By Technology(Revenue, USD Million, 2021-2031) |
6.2.1 Overview and Analysis |
6.2.2 Samoa Oncology Companion Diagnostic Market Revenues & Volume, By Polymerase chain reaction (PCR), 2021- 2031F |
6.2.3 Samoa Oncology Companion Diagnostic Market Revenues & Volume, By Next-generation sequencing (NGS), 2021- 2031F |
6.2.4 Samoa Oncology Companion Diagnostic Market Revenues & Volume, By Immunohistochemistry (IHC), 2021- 2031F |
6.2.5 Samoa Oncology Companion Diagnostic Market Revenues & Volume, By In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH), 2021- 2031F |
6.2.6 Samoa Oncology Companion Diagnostic Market Revenues & Volume, By Other technologies, 2021- 2031F |
6.3 Samoa Oncology Companion Diagnostic Market, By Type |
6.3.1 Overview and Analysis |
6.3.2 Samoa Oncology Companion Diagnostic Market Revenues & Volume, By Breast cancer, 2021- 2031F |
6.3.3 Samoa Oncology Companion Diagnostic Market Revenues & Volume, By Non-small cell lung cancer, 2021- 2031F |
6.3.4 Samoa Oncology Companion Diagnostic Market Revenues & Volume, By Colorectal cancer, 2021- 2031F |
6.3.5 Samoa Oncology Companion Diagnostic Market Revenues & Volume, By Leukemia, 2021- 2031F |
6.3.6 Samoa Oncology Companion Diagnostic Market Revenues & Volume, By Melanoma, 2021- 2031F |
6.3.7 Samoa Oncology Companion Diagnostic Market Revenues & Volume, By Prostate cancer, 2021- 2031F |
6.4 Samoa Oncology Companion Diagnostic Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 Samoa Oncology Companion Diagnostic Market Revenues & Volume, By Hospital, 2021- 2031F |
6.4.3 Samoa Oncology Companion Diagnostic Market Revenues & Volume, By Pathology/Diagnostic laboratory, 2021- 2031F |
6.4.4 Samoa Oncology Companion Diagnostic Market Revenues & Volume, By Academic medical center, 2021- 2031F |
7 Samoa Oncology Companion Diagnostic Market Import-Export Trade Statistics |
7.1 Samoa Oncology Companion Diagnostic Market Export to Major Countries |
7.2 Samoa Oncology Companion Diagnostic Market Imports from Major Countries |
8 Samoa Oncology Companion Diagnostic Market Key Performance Indicators |
8.1 Number of oncology companion diagnostic tests conducted annually in Samoa |
8.2 Adoption rate of personalized medicine in oncology |
8.3 Investments in research and development of new diagnostic technologies for oncology companion diagnostics |
9 Samoa Oncology Companion Diagnostic Market - Opportunity Assessment |
9.1 Samoa Oncology Companion Diagnostic Market Opportunity Assessment, By Product & Service, 2021 & 2031F |
9.2 Samoa Oncology Companion Diagnostic Market Opportunity Assessment, By Technology(Revenue, USD Million, 2021-2031), 2021 & 2031F |
9.3 Samoa Oncology Companion Diagnostic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.4 Samoa Oncology Companion Diagnostic Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Samoa Oncology Companion Diagnostic Market - Competitive Landscape |
10.1 Samoa Oncology Companion Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Samoa Oncology Companion Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here